Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis

Abstract Background Cystic echinococcosis (CE) is a common neglected parasitic disease. Nanoparticles containing drugs have been widely utilized in various formulations for several purposes, including improving the bioavailability of drugs by increasing the solubility and dissolution rate of the nan...

Full description

Saved in:
Bibliographic Details
Main Authors: Fariba Faizi, Reza Mahjub, Negin Torabi, Seyedmousa Motavallihaghi, Mohammad Fallah
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Parasites & Vectors
Subjects:
Online Access:https://doi.org/10.1186/s13071-024-06473-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850035273729048576
author Fariba Faizi
Reza Mahjub
Negin Torabi
Seyedmousa Motavallihaghi
Mohammad Fallah
author_facet Fariba Faizi
Reza Mahjub
Negin Torabi
Seyedmousa Motavallihaghi
Mohammad Fallah
author_sort Fariba Faizi
collection DOAJ
description Abstract Background Cystic echinococcosis (CE) is a common neglected parasitic disease. Nanoparticles containing drugs have been widely utilized in various formulations for several purposes, including improving the bioavailability of drugs by increasing the solubility and dissolution rate of the nanoparticles. The purpose of this study was to evaluate the effects of solid lipid nanoparticles containing albendazole and conjugated to albumin (B-SLN + ABZ) as a novel treatment approach for hydatid cysts in vivo. Methods Albendazole-loaded solid lipid nanoparticles were prepared by emulsification and solvent evaporation method. The experimental mice were assessed for prophylactic and therapeutic effects of the drugs. Ultrastructural changes were observed by transmission electron microscopy. Results The variance analysis of the fitted model indicated that the Glyceryl monostearate (GMS)/soy lecithin concentration ratio and the amount of albendazole had a significant effect on nanoparticle size. The GMS/soy lecithin concentration ratio and the amount of albendazole had a notable effect on nanoparticle polydispersity index (PdI) and entrapment efficiency (EE%), respectively. During chemoprophylaxis, the B-SLN + ABZ group showed a lower number and weight of cysts (0.90 ± 0.73 and 15.01 ± 10.46, respectively) compared with the ABZ + SLN group (1.4 ± 0.51 and 26.73 ± 9.92, respectively). In addition, therapeutic efficacy analysis showed a significant reduction in wet weights of metacestodes in mice treated with both B-SLN + ABZ (29.37 ± 13.82 mg) and SLN + ABZ (35.88 ± 7.49 mg) compared with the control group (59.78 ± 3.80 mg). Conclusions The results showed that B-SLN + ABZ nanoparticles were more effective against E. granulosus cysts compared with free ABZ. The cysts in the animals receiving B-SLN + ABZ every 24 h showed more ultrastructural changes. Graphical abstract
format Article
id doaj-art-fd63eef5ad3048d9b847c20d1aef3e81
institution DOAJ
issn 1756-3305
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj-art-fd63eef5ad3048d9b847c20d1aef3e812025-08-20T02:57:32ZengBMCParasites & Vectors1756-33052024-12-0117111510.1186/s13071-024-06473-5Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosisFariba Faizi0Reza Mahjub1Negin Torabi2Seyedmousa Motavallihaghi3Mohammad Fallah4Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical SciencesFaculty of Pharmacy, Hamadan University of Medical SciencesDepartment of Parasitology and Mycology, School of Medicine, Zanjan University of Medical SciencesDepartment of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical SciencesDepartment of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical SciencesAbstract Background Cystic echinococcosis (CE) is a common neglected parasitic disease. Nanoparticles containing drugs have been widely utilized in various formulations for several purposes, including improving the bioavailability of drugs by increasing the solubility and dissolution rate of the nanoparticles. The purpose of this study was to evaluate the effects of solid lipid nanoparticles containing albendazole and conjugated to albumin (B-SLN + ABZ) as a novel treatment approach for hydatid cysts in vivo. Methods Albendazole-loaded solid lipid nanoparticles were prepared by emulsification and solvent evaporation method. The experimental mice were assessed for prophylactic and therapeutic effects of the drugs. Ultrastructural changes were observed by transmission electron microscopy. Results The variance analysis of the fitted model indicated that the Glyceryl monostearate (GMS)/soy lecithin concentration ratio and the amount of albendazole had a significant effect on nanoparticle size. The GMS/soy lecithin concentration ratio and the amount of albendazole had a notable effect on nanoparticle polydispersity index (PdI) and entrapment efficiency (EE%), respectively. During chemoprophylaxis, the B-SLN + ABZ group showed a lower number and weight of cysts (0.90 ± 0.73 and 15.01 ± 10.46, respectively) compared with the ABZ + SLN group (1.4 ± 0.51 and 26.73 ± 9.92, respectively). In addition, therapeutic efficacy analysis showed a significant reduction in wet weights of metacestodes in mice treated with both B-SLN + ABZ (29.37 ± 13.82 mg) and SLN + ABZ (35.88 ± 7.49 mg) compared with the control group (59.78 ± 3.80 mg). Conclusions The results showed that B-SLN + ABZ nanoparticles were more effective against E. granulosus cysts compared with free ABZ. The cysts in the animals receiving B-SLN + ABZ every 24 h showed more ultrastructural changes. Graphical abstracthttps://doi.org/10.1186/s13071-024-06473-5AlbendazoleAlbuminSolid lipid nanoparticlesHydatid cyst
spellingShingle Fariba Faizi
Reza Mahjub
Negin Torabi
Seyedmousa Motavallihaghi
Mohammad Fallah
Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis
Parasites & Vectors
Albendazole
Albumin
Solid lipid nanoparticles
Hydatid cyst
title Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis
title_full Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis
title_fullStr Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis
title_full_unstemmed Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis
title_short Cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis
title_sort cationized albumin conjugated solid lipid nanoparticles as vectors for delivery of albendazole against cystic echinococcosis
topic Albendazole
Albumin
Solid lipid nanoparticles
Hydatid cyst
url https://doi.org/10.1186/s13071-024-06473-5
work_keys_str_mv AT faribafaizi cationizedalbuminconjugatedsolidlipidnanoparticlesasvectorsfordeliveryofalbendazoleagainstcysticechinococcosis
AT rezamahjub cationizedalbuminconjugatedsolidlipidnanoparticlesasvectorsfordeliveryofalbendazoleagainstcysticechinococcosis
AT negintorabi cationizedalbuminconjugatedsolidlipidnanoparticlesasvectorsfordeliveryofalbendazoleagainstcysticechinococcosis
AT seyedmousamotavallihaghi cationizedalbuminconjugatedsolidlipidnanoparticlesasvectorsfordeliveryofalbendazoleagainstcysticechinococcosis
AT mohammadfallah cationizedalbuminconjugatedsolidlipidnanoparticlesasvectorsfordeliveryofalbendazoleagainstcysticechinococcosis